Verastem VSTM
NASDAQ VSTM
$8.20 +0.22 (+2.82%)
As of: Sep 4, 2026 · 3:59 PM EDT

Verastem (VSTM) Enterprise Value (2012 - 2026)

Verastem (VSTM) posted quarterly Enterprise Value of -$197.8 million for Q1 2026, down 68.26% year-over-year from -$623.4 million in Q1 2025, and up 3.49% quarter-over-quarter from -$205.0 million in Q4 2025.

Analysis

Verastem (VSTM) Enterprise Value (2012 - 2026) Analysis & Trends

Verastem's Enterprise Value history runs 16 years deep, the most recent figure standing at -$197.8 million for Q1 2026.

  • In Q1 2026, Enterprise Value fell 68.26% year-over-year to -$197.8 million; the TTM figure through Mar 2026 stood at -$197.8 million (down 68.26% YoY), while the FY2025 annual figure was -$205.0 million, down 130.8% from the prior year.
  • Enterprise Value for Q1 2026 stood at -$197.8 million, up from -$205.0 million in the prior quarter.
  • The five-year high for Enterprise Value was -$83.4 million in Q2 2024, with the low at -$205.0 million in Q4 2025.
  • The 5-year median for Enterprise Value is -$113.2 million (2024), against an average of -$130.1 million.
  • The sharpest annual moves came in 2024 and 2025: Enterprise Value surged 54.46% in 2024, then tumbled 130.8% in 2025.
  • Verastem's Enterprise Value stood at -$92.0 million in 2022, then slumped by 48.99% to -$137.1 million in 2023, then soared by 35.23% to -$88.8 million in 2024, then plunged by 130.8% to -$205.0 million in 2025, then increased by 3.49% to -$197.8 million in 2026.
  • Business Quant data shows VSTM's Enterprise Value at -$197.8 million in Q1 2026, -$205.0 million in Q4 2025, and -$137.7 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Verastem 814.94 Mn 678.59 Mn 36.32 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 209.29 Mn
Mar 31, 2026 267.74 Mn
Dec 31, 2025 395.16 Mn
Sep 30, 2025 451.69 Mn
Jun 30, 2025 91.00 Mn
Mar 31, 2025 192.92 Mn
Dec 31, 2024 95.82 Mn
Sep 30, 2024 7.21 Mn
Jun 30, 2024 -3.28 Mn
Mar 31, 2024 188.51 Mn
Dec 31, 2023 68.66 Mn
Sep 30, 2023 39.74 Mn
Jun 30, 2023 -51.16 Mn
Mar 31, 2023 -26.98 Mn
Dec 31, 2022 -7.68 Mn
Sep 30, 2022 74.59 Mn
Jun 30, 2022 123.32 Mn
Mar 31, 2022 156.44 Mn
Dec 31, 2021 279.57 Mn
Sep 30, 2021 457.60 Mn